Inactive Instrument

Company Pfizer Inc Nyse

Equities

Pharmaceuticals

End-of-day quote Nyse
- USD 0.00% Intraday chart for Pfizer Inc

Business Summary

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:

- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;

- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;

- oncology products (12.1%);

- other (1.3%).

At the end of 2022, the group had more than 35 manufacturing sites worldwide.

Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).

Sales per Business

USD in Million2022Weight2023Weight Delta
Biopharma
97.8 %
98,988 98.7 % 57,186 97.8 % -42.23%
Other Business Activities
2.2 %
1,342 1.3 % 1,310 2.2 % -2.38%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
46.3 %
42,473 42.3 % 27,088 46.3 % -36.22%
Emerging Markets
20.5 %
20,097 20.0 % 11,996 20.5 % -40.31%
Developed Europe
19.9 %
21,982 21.9 % 11,650 19.9 % -47.00%
Developed Rest of World
7.3 %
7,752 7.7 % 4,251 7.3 % -45.16%
Japan
6.0 %
8,026 8.0 % 3,510 6.0 % -56.27%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Chief Tech/Sci/R&D Officer - 06-12-31
Chief Tech/Sci/R&D Officer 55 -
Chief Tech/Sci/R&D Officer - 20-12-31
Compliance Officer 63 93-12-31
Chief Tech/Sci/R&D Officer 65 09-09-30
Chief Tech/Sci/R&D Officer 60 22-08-31
Investor Relations Contact - 21-07-18

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
Director/Board Member 66 07-08-31
Director/Board Member 51 19-06-26
Director/Board Member 64 14-06-25
Director/Board Member 71 11-12-11
Director/Board Member 59 20-02-26
Director/Board Member 66 15-06-24
Chief Executive Officer 62 92-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,578,541,291 5,643,981,394 ( 58.92 %) 3,916,000,000 ( 40.88 %) 58.92 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
8.970 %
506,517,466 8.970 % 13 453 M $
BlackRock Advisors LLC
5.801 %
327,557,452 5.801 % 8 700 M $
287,482,006 5.091 % 7 636 M $
Wellington Management Co. LLP
4.236 %
239,209,768 4.236 % 6 353 M $
Capital Research & Management Co. (World Investors)
3.071 %
173,394,272 3.071 % 4 605 M $
Geode Capital Management LLC
1.940 %
109,534,217 1.940 % 2 909 M $
Charles Schwab Investment Management, Inc.
1.846 %
104,246,432 1.846 % 2 769 M $
ishares (DE) Invag Mit Teilgesellschaftsvermogen
1.579 %
89,163,152 1.579 % 2 368 M $
Eaton Vance Management
1.454 %
82,106,536 1.454 % 2 181 M $
Norges Bank (13F)
1.310 %
73,981,480 1.310 % 1 965 M $
NameEquities%Valuation
Caixa DTVM SA
0.001590 %
359,072 0.001590 % 2 M $
BB Gestão de Recursos DTVM SA
0.001196 %
270,235 0.001196 % 2 M $
Itaú Unibanco SA
0.000612 %
138,180 0.000612 % 923 305 $
Bram Bradesco Asset Management S/A DTVM
0.000255 %
57,558 0.000255 % 384 597 $
BTG Pactual WM Gestão de Recursos Ltda.
0.000046 %
10,431 0.000046 % 69 699 $
XP Allocation Asset Management Ltda.
0.000038 %
8,601 0.000038 % 57 471 $
Finaxis CTVM SA (Investment Management)
0.000009 %
2,000 0.000009 % 13 364 $

Holdings

NameEquities%Valuation
2,955,063,626 32.00% 12,389,636,163 $
29,243,042 63.92% 1,621,877,303 $
27,349,211 15.06% 1,121,317,651 $
3,457,815 5.08% 158,990,334 $
22,032,040 13.09% 108,177,316 $
5,376,344 7.98% 68,494,623 $
2,525,252 4.53% 68,156,551 $
1,272,214 4.96% 49,387,347 $
7,032,770 15.87% 44,728,417 $
4,690,431 5.30% 37,101,309 $

Company contact information

Pfizer Inc.

66 Hudson Boulevard East

10001-2192, New York

+212 733 2323

http://www.pfizer.com
address Pfizer Inc

Group companies

NameCategory and Sector
Chemicals: Agricultural
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Other
Pharmaceuticals: Major